These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 10470596
1. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis. Bianchi Porro G, Montrone F, Lazzaroni M, Manzionna G, Caruso I. Ital J Gastroenterol Hepatol; 1999; 31(5):378-85. PubMed ID: 10470596 [Abstract] [Full Text] [Related]
2. [A clinical study on the anti-inflammatory activity and gastrointestinal tolerability of amtolmetin guacyl, a new NSAID, compared with diclofenac in aged patients with osteoarticular diseases]. Tavella A, Ursini G. Clin Ter; 1997 Nov; 148(11):543-8. PubMed ID: 9494257 [Abstract] [Full Text] [Related]
3. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study. Lazzaroni M, Anderloni A, Bianchi Porro G. Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):833-9. PubMed ID: 11474314 [Abstract] [Full Text] [Related]
4. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis. Jajić Z, Malaise M, Nekam K, Koó E, Dankó K, Kovacs M, Scarpignato C. Clin Exp Rheumatol; 2005 Jul; 23(6):809-18. PubMed ID: 16396699 [Abstract] [Full Text] [Related]
5. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G, Lazzaroni M, Petrillo M. Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [Abstract] [Full Text] [Related]
6. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial. Pavelka K, Recker DP, Verburg KM. Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937 [Abstract] [Full Text] [Related]
7. [Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis]. Biasi G, Marcolongo R. Minerva Med; 2001 Oct; 92(5):315-24. PubMed ID: 11675575 [Abstract] [Full Text] [Related]
8. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S. Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449 [Abstract] [Full Text] [Related]
9. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group. Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG. J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107 [Abstract] [Full Text] [Related]
10. Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase. Coruzzi G, Coppelli G, Spaggiari S, Cavestro GM, Okolicsanyi L, Lo Giudice P, Pisano C, Tepperman BL. Dig Liver Dis; 2002 Jun; 34(6):403-10. PubMed ID: 12132787 [Abstract] [Full Text] [Related]
11. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs. Kirkova M, Alexandova A, Kesiova M, Todorov S. Auton Autacoid Pharmacol; 2007 Apr; 27(2):99-104. PubMed ID: 17391279 [Abstract] [Full Text] [Related]
12. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients. Miglioli M, Bianchi Porro G, Vaira D, Menegatti M, Brunetti G, Petrillo M, Ardizzone S, Frizziero L, Montrone F, Grandinetti G. Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419 [Abstract] [Full Text] [Related]
13. Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis. Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, Feng H, Parsons B. Int J Rheum Dis; 2010 May; 13(2):151-7. PubMed ID: 20536600 [Abstract] [Full Text] [Related]
14. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study. Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I. Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264 [Abstract] [Full Text] [Related]
15. Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl. Tubaro E, Belogi L, Mezzadri CM, Ruco L, Stopacciaro A. Arzneimittelforschung; 1995 Dec; 45(12):1298-302. PubMed ID: 8595088 [Abstract] [Full Text] [Related]
16. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration]. Wildgrube HJ, Kierschke G, Nowak H, Weigmann I, Terhaag B. Arzneimittelforschung; 2002 Dec; 52(4):264-72. PubMed ID: 12040969 [Abstract] [Full Text] [Related]
17. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis. Ciompi ML, Puccetti L, Bazzichi L, Remorini E, Marotta G. Int J Clin Pharmacol Res; 1989 Dec; 9(3):217-22. PubMed ID: 2526101 [Abstract] [Full Text] [Related]
18. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. Thomson AB, Marshall JK, Hunt RH, Provenza JM, Lanza FL, Royer MG, Li Z, Blank MA, Risedronate Endoscopy Study Group. J Rheumatol; 2002 Sep; 29(9):1965-74. PubMed ID: 12233894 [Abstract] [Full Text] [Related]
19. Diclofenac/misoprostol: the European clinical experience. McKenna F. J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551 [Abstract] [Full Text] [Related]
20. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS. Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141 [Abstract] [Full Text] [Related] Page: [Next] [New Search]